Company Description. Immunomic Therapeutics, Inc. (ITI) an HLB Company, is a privately-held, clinical-stage biotechnology company pioneering the development of vaccines through its proprietary technology platform UNITE®, which is designed to utilize the body’s natural biochemistry to develop vaccines that generate broad immune responses. ITI is primarily focused on applying the UNITE® platform to oncology indications, where it could potentially h...
